This is a routine initial beneficial ownership filing with no trading activity. Monitor for future Form 4 filings or IPO-related disclosures that could signal changes in Redmile's position or conversion of preferred shares.
Price Chart
Executive Summary
Redmile Group, LLC, Jeremy Green, and Redmile Biopharma Investments III, L.P. filed a Form 3 initial statement of beneficial ownership for Attovia Therapeutics, Inc. (ATTO), disclosing ownership of 782,854 shares of common stock (adjusted for a 1-for-9.29 reverse stock split on July 29, 2026) and Series B Preferred Stock convertible into common stock at the holder's election or automatically upon IPO closing. This is a routine initial ownership filing by a pre-IPO investor, indicating no new transaction or change in position.
Key Facts
- Redmile Group and related entities filed a Form 3 initial statement of beneficial ownership for Attovia Therapeutics (ATTO).
- The filing discloses 782,854 shares of common stock owned by Redmile Biopharma Investments III, L.P., after a 1-for-9.29 reverse stock split on July 29, 2026.
- The filing also reports ownership of Series B Preferred Stock, convertible into common stock at the holder's election or automatically upon an IPO.
- This is a standard initial ownership report (Form 3) with no new transactions or changes in position.
Financial Impact
No financial impact; routine initial ownership disclosure with no transaction. Ownership of 782,854 common shares and convertible Series B Preferred Stock disclosed.
Risk Factors
- No material risks identified from this routine filing.
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001104659-26-090604 |
| Document: 0001104659-26-090604-index.html | 0001104659-26-090604 |
| Document: 0001104659-26-090604.txt | 0001104659-26-090604 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 8, 2026 19d ago | 3/A | $16.21 | awaiting T+20 | — | $15.00 (−7.46%) |
Oct 8, 2026 19d ago | 3/A | $16.21 | awaiting T+20 | — | $15.00 (−7.46%) |
Sep 28, 2026 29d ago | Press Release | $18.16 $15.00 | ▼ −17.40% | ▼ −18.12% | $15.00 (−17.40%) |
Sep 2, 2026 7w ago | Press Release | $24.20 $17.14 | ▼ −29.17% | ▼ −28.06% | $15.00 (−38.02%) |
Aug 28, 2026 8w ago | 144 / CLUSTER | $21.40 $18.16 | ▼ −15.14% | ▼ −14.95% | $15.00 (−29.91%) |
Aug 13, 2026 10w ago | Insider Buy | $19.86 $24.52 | ▲ +23.46% | ▲ +25.46% | $15.00 (−24.47%) |
Aug 13, 2026 10w ago | Insider Cluster | $19.86 $24.52 | ▲ +23.46% | ▲ +25.46% | $15.00 (−24.47%) |
Aug 10, 2026 11w ago | Insider Cluster | $18.65 $22.86 | ▲ +22.57% | ▲ +23.63% | $15.00 (−19.57%) |
Aug 7, 2026 11w ago | Insider Cluster | $19.84 $23.66 | ▲ +19.25% | ▲ +20.17% | $15.00 (−24.40%) |
Aug 7, 2026 11w ago | Insider Cluster | $20.17 $25.55 | ▲ +26.67% | ▲ +27.07% | $15.00 (−25.63%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers